Periodontal Diseases and COVID-19: A Scoping Review

Abstract

The aim of this scoping review was to present the existing literature regarding the relationship between periodontal diseases and coronavirus disease 2019 (COVID-19). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping review guidelines was followed. Articles were retrieved from PubMed/MEDLINE and Scopus databases and screened to include studies relating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 to periodontal cells and/or tissues and/or diseases. Twenty-five papers were included; consisting of six reviews, seven original articles, six short reports, four letters to the editor, one commentary, and one case report. The articles were allocated to three different topics: (i) hypotheses on the relationship between periodontal diseases and COVID-19; (ii) risk factors and comorbidities common to periodontitis and COVID-19; (iii) periodontal manifestations of COVID-19. Certain molecules (angiotensin-converting enzyme-2, furin, cathepsin, TMPRSS2...) that are found at a high level in periodontal tissues, particularly in patients with periodontitis, are involved in the mechanism of entry of SARS-CoV-2 into cells. Periodontopathic bacteria could also play a direct role in the mechanism of entry of SARS-CoV-2 by cleaving the S-protein, and the cytokines produced during periodontitis could add to the cytokine storm found in the severe forms of COVID-19. It thus appears that the treatment of periodontitis, which allows a reduction in periodontopathic bacteria and of the local and systemic inflammation state, could be part of a strategy to prevent the development of severe forms of COVID-19.

Keywords

coronavirus - risk factors - oral health - periodontitis

^* *These are the co-first authors for this article.

Publication History

Article published online:
09 September 2021

• References

• 1 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5 (04) 536-544
• 2 Zhu N, Zhang D, Wang W. et al China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
• 3 WHO Coronavirus Disease (COVID-19) Dashboard. Accessed February 17, 2021 at: https://covid19.who.int
• 4 CDC. COVID-19 and Your Health. Centers for Disease Control and Prevention. Accessed January 21, 2021 at: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/ people-with-medical-conditions.htm
• 5 Mark P Bartold, Mariotti A. The future of periodontal-systemic associations: raising the standards. Curr Oral Health Rep 2017; 4 (03) 258-262
• 6 Vincent RR, Appukuttan D, Victor DJ, Balasundaram A. Oxidative stress in chronic periodontitis patients with type II diabetes mellitus. Eur J Dent 2018; 12 (02) 225-231
• 7 Glurich I, Acharya A. Updates from the evidence base examining association between periodontal disease and type 2 diabetes mellitus: current status and clinical relevance. Curr Diab Rep 2019; 19 (11) 121
• 8 Wang J, Yang X, Zou X, Zhang Y, Wang J, Wang Y. Relationship between periodontal disease and lung cancer: a systematic review and meta-analysis. J Periodontal Res 2020; 55 (05) 581-593
• 9 Xiao L, Zhang Q, Peng Y, Wang D, Liu Y. The effect of periodontal bacteria infection on incidence and prognosis of cancer: a systematic review and meta-analysis. Medicine (Baltimore) 2020; 99 (15) e19698
• 10 Heji ES, Bukhari AA, Bahammam MA, Homida LA, Aboalshamat KT, Aldahlawi SA. Periodontal disease as a predictor of undiagnosed diabetes or prediabetes in dental patients. Eur J Dent 2021; 15 (02) 216-221 Doi:
• 11 Tricco AC, Lillie E, Zarin W. et al PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018; 169 (07) 467-473
• 12 Kadkhodazadeh M, Amid R, Moscowchi A. Does COVID-19 affect periodontal and peri-implant diseases?. J Long Term Eff Med Implants 2020; 30 (01) 1-2
• 13 Xu H, Zhong L, Deng J. et al High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020; 12 (01) 8
• 14 Zhong M, Lin B, Gao H. et al Significant expression of FURIN and ACE2 on oral epithelial cells may facilitate the efficiency of SARS-CoV-2 entry. BioRxiv 2020; doi:
• 15 Botros N, Iyer P, Ojcius DM. Is there an association between oral health and severity of COVID-19 complications?. Biomed J 2020; 43 (04) 325-327
• 16 Badran Z, Gaudin A, Struillou X, Amador G, Soueidan A. Periodontal pockets: A potential reservoir for SARS-CoV-2?. Med Hypotheses 2020; 143: 109907
• 17 Sahni V, Gupta S. COVID-19 & Periodontitis: the cytokine connection. Med Hypotheses 2020; 144: 109908
• 18 Madapusi Balaji T, Varadarajan S, Rao USV. et al Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression. Med Hypotheses 2020; 144: 109936
• 19 Gupta S, Sahni V. The intriguing commonality of NETosis between COVID-19 & periodontal disease. Med Hypotheses 2020; 144: 109968
• 20 Patel J, Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID-19. Oral Dis 2021; 27 (Suppl. 03) 768-769 doi:
• 21 Pfützner A, Lazzara M, Jantz J. Why do people with diabetes have a high risk for severe COVID-19 disease?-a dental hypothesis and possible prevention strategy. J Diabetes Sci Technol 2020; 14 (04) 769-771
• 22 Pitones-Rubio V, Chávez-Cortez EG, Hurtado-Camarena A, González-Rascón A, Serafín-Higuera N. Is periodontal disease a risk factor for severe COVID-19 illness?. Med Hypotheses 2020; 144: 109969
• 23 Sampson V, Kamona N, Sampson A. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?. Br Dent J 2020; 228 (12) 971-975
• 24 Bertolini M, Pita A, Koo S, Cardenas A, Meethil A. Periodontal disease in the COVID-19 era: potential reservoir and increased risk for SARS-CoV-2. Pesqui Bras Odontopediatria Clin Integr 2020; 20 (Suppl. 01) e0134
• 25 Pedrosa MDS, Neves Nogueira F. COVID-19 and diabetes: what should we expect?. J Diabetes Sci Technol 2020; 14 (06) 1133-1134
• 26 Sakaguchi W, Kubota N, Shimizu T. et al Existence of SARS-CoV-2 entry molecules in the oral cavity. Int J Mol Sci 2020; 21 (17) E6000
• 27 Kara C, Çelen K, Dede FÖ, Gökmenoğlu C, Kara NB. Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3. Exp Biol Med (Maywood) 2020; 245 (16) 1425-1427
• 28 Mancini L, Quinzi V, Mummolo S, Marzo G, Marchetti E. Angiotensin-converting enzyme 2 as a possible correlation between COVID-19 and periodontal disease. Appl Sci (Basel) 2020; 10 (18) 6224
• 29 Räisänen IT, Umeizudike KA, Pärnänen P. et al Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era. Med Hypotheses 2020; 144: 110276
• 30 Elisetti N. Periodontal pocket and COVID-19: could there be a possible link?. Med Hypotheses 2021; 146: 110355
• 31 Gupta S, Mohindra R, Chauhan PK. et al SARS-CoV-2 detection in gingival crevicular fluid. J Dent Res 2021; 100 (02) 187-193
• 32 Takahashi Y, Watanabe N, Kamio N, Kobayashi R, Iinuma T, Imai K. Aspiration of periodontopathic bacteria due to poor oral hygiene potentially contributes to the aggravation of COVID-19. J Oral Sci 2020; 63 (01) 1-3
• 33 Larvin H, Wilmott S, Wu J. Kang J. The impact of periodontal disease on hospital admission and mortality during COVID-19 pandemic. Front Med (Lausanne) 2020; 7: 604980
• 34 Fernandes Matuck B, Dolhnikoff M, Maia GVA. et al Periodontal tissues are targets for Sars-Cov-2: a post-mortem study. J Oral Microbiol 2020; 13 (01) 1848135
• 35 Gofur N. Impact of SARS-CoV-2 on periodontal tissue manifestation. J Int Oral Health 2020; 12 (08) 90-92
• 36 Roganović JR. MicroRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptors genes. J Periodontol 2020; 10.1002/JPER.20-0623 doi:
• 37 Esteves-Lima RP, Pereira Gde M. Impact of periodontal condition for individuals with COVID-19. J Oral Res 2020; 20-22
• 38 Vieira AR. Oral manifestations in coronavirus disease 2019 (COVID-19).. Oral Dis 2021; 27 (Suppl 3):770 doi:
• 39 Al-Bayaty FH. Impact of COVID-19 on periodontal therapy: an overview. J Oral Res 2020; Covid-19 S2(1):10-13 doi:
• 40 Daly J, Black EAM. The impact of COVID-19 on population oral health. Community Dent Health 2020; 37 (04) 236-238
• 41 Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: a review article. Dermatol Ther (Heidelb) 2021; 34 (01) e14578
• 42 Frankenberger R. Oral immunocompetence in the corona pandemic vs. system relevance of dentistry. Gesund Oekon Qual Manag 2020; 25 (05) 256-263 doi:
• 43 Ramadan DE, Hariyani N, Indrawati R, Ridwan RD, Diyatri I. Cytokines and chemokines in periodontitis. Eur J Dent 2020; 14 (03) 483-495
• 44 Demmer RT, Trinquart L, Zuk A. et al The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2013; 8 (10) e77441
• 45 Baeza M, Morales A, Cisterna C. et al Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis. J Appl Oral Sci 2020; 28: e20190248
• 46 Delbove T, Gueyffier F, Juillard L. et al Effect of periodontal treatment on the glomerular filtration rate, reduction of inflammatory markers and mortality in patients with chronic kidney disease: a systematic review. PLoS One 2021; 16 (01) e0245619
• 47 Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366 (9499) 1809-1820
• 48 Martín Carreras-Presas C, Amaro Sánchez J, López-Sánchez AF, Jané-Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis 2021; 27 (Suppl. 03) 710-712 doi: